Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taitai Gubao Granules in Postmenopausal Osteoporosis (Phase II)
CTR20132926Phase 2Active
- Sponsor
- Chengdu Kang'ao Pharmaceutical Research Institute
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Taitai Gubao Granules in postmenopausal osteoporosis, sponsored by Chengdu Kang'ao Pharmaceutical Research Institute. Started Feb 2014; status: active.
02
Drugs
Taitai Gubao Granules
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on CTR20132926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132926.